Real-life dosing with second-generation antipsychotics

被引:11
|
作者
Correll, CU [1 ]
机构
[1] Zucker Hillside Hosp, Glen Oaks, NY 11004 USA
关键词
D O I
10.4088/JCP.v66n1218
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
[No abstract available]
引用
收藏
页码:1610 / 1611
页数:2
相关论文
共 50 条
  • [41] Second-generation antipsychotics and constipation: A review of the literature
    De Hert, M.
    Hudyana, H.
    Dockx, L.
    Bernagie, C.
    Sweers, K.
    Tack, J.
    Leucht, S.
    Peuskens, J.
    EUROPEAN PSYCHIATRY, 2011, 26 (01) : 34 - 44
  • [42] Prescription of Second-Generation Antipsychotics: Responding to Treatment Risk in Real-World Practice
    Hermes, Eric D. A.
    Sernyak, Michael J.
    Rosenheck, Robert A.
    PSYCHIATRIC SERVICES, 2013, 64 (03) : 238 - 244
  • [43] Dosing equivalency of second-generation antipsychotic medications
    Buckley, PF
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2005, 25 (05) : 501 - 502
  • [44] Outcome of older myeloma patients in relationship to comorbidities and availability of second-generation novel agents in a real-life setting
    d'Epinay, Murielle Lalive
    Guesewell, Sabine
    Graf, Nicole
    Mey, Ulrich J. M.
    Driessen, Christoph
    Hitz, Felicitas
    HEMATOLOGICAL ONCOLOGY, 2022, 40 (04) : 716 - 723
  • [45] Second generation antipsychotics in 'real-life' paediatric patients. Adverse drug reactions and clinical outcomes of drug switch
    Rafaniello, Concetta
    Pozzi, Marco
    Pisano, Simone
    Ferrajolo, Carmen
    Bertella, Silvana
    Sportiello, Liberata
    Carnovale, Carla
    Sullo, Maria Giuseppa
    Cattaneo, Dario
    Gentili, Marta
    Rizzo, Renata
    Pascotto, Antonio
    Mani, Elisa
    Villa, Laura
    Riccio, Maria Pia
    Sperandeo, Serena
    Bernardini, Renato
    Bravaccio, Carmela
    Clementi, Emilio
    Molteni, Massimo
    Rossi, Francesco
    Radice, Sonia
    Capuano, Annalisa
    Expert Opinion On Drug Safety, 2016, 15 : 1 - 8
  • [46] Second-generation antipsychotics and metabolic syndrome: a role for mitochondria
    Mortimer, Katherine R. H.
    Katshu, Mohammed Zia Ul Haq
    Chakrabarti, Lisa
    FRONTIERS IN PSYCHIATRY, 2023, 14
  • [47] Second-generation antipsychotics in children Risks and monitoring needs
    Lambert, Clare
    Panagiotopoulos, Constadina
    Davidson, Jana
    Goldman, Ran D.
    CANADIAN FAMILY PHYSICIAN, 2018, 64 (09) : 660 - 662
  • [48] OFF-LABEL USE OF SECOND-GENERATION ANTIPSYCHOTICS
    Spina, Edoardo
    Fava, Giuseppina
    Makos, Xenofon
    CLINICAL NEUROPSYCHIATRY, 2009, 6 (01): : 11 - 20
  • [49] Weighing in: Emergent diabetes mellitus and second-generation antipsychotics
    Dufresne, Robert L.
    ANNALS OF PHARMACOTHERAPY, 2007, 41 (10) : 1725 - 1727
  • [50] Review: metabolic side effects of second-generation antipsychotics
    Johnsen, Erik
    EVIDENCE-BASED MENTAL HEALTH, 2011, 14 (02) : 47 - 47